Post by Radboudumc Therapy Accelerator for Rare Diseases

Great news! Our colleague Rick Greupink has been appointed Associate Professor in the field of Translational Pharmacology and Drug Development Education at Radboudumc. The Associate professor position helps to establish Radboudumc as a leading education center in in this field, by curriculum development and by developing a learning ecosystem of academic and non-academic partners. One of the initiatives is the development of a new Master’s track on Cell, Drug and Gene Therapy development within the Biomedical Sciences program. Rick: 'The track aims to enhance Radboudumc’s capacity to train the next generation of (research) professionals who can contribute to the different stages of therapy development in general, with an accent on therapy development for rare diseases' Congratulations Rick! #Radboudumc #Education #Research #DrugDevelopment #RARENL